The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib

被引：0
|
作者：
Strand, Vibeke [1 ]
Damjanov, Nemanja [2 ]
Scoville, Craig [3 ]
Tundia, Namita [4 ]
Camp, Heidi S. [4 ]
Chen, Kun [4 ]
Suboticki, Jessica [4 ]
van Vollenhoven, Ronald [5 ]
机构：
[1] Stanford Univ, Div Immunol Rheumatol, Palo Alto, CA 94304 USA
[2] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia
[3] Idaho Falls Arthrit Clin, Idaho Falls, ID USA
[4] AbbVie Inc, N Chicago, IL USA
[5] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2546
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials
    Fleischmann, Roy
    Bessette, Louis
    Sparks, Jeffrey
    Hall, Stephen
    Jain, Manish
    Kakehasi, Adriana
    Song, Yanna
    Meerwein, Sebastian
    DeMasi, Ryan
    Suboticki, Jessica
    Rubbert-Roth, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 541 - 543
  • [22] Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naive patients with rheumatoid arthritis
    Fleischmann, Roy
    Strand, Vibeke
    Wilkinson, Bethanie
    Kwok, Kenneth
    Bananis, Eustratios
    RMD OPEN, 2016, 2 (01):
  • [23] POPULATION PHARMACOKINETICS OF UPADACITINIB IN HEALTHY SUBJECTS AND SUBJECTS WITH RHEUMATOID ARTHRITIS: ANALYSES OF PHASE I TO III CLINICAL TRIALS.
    Klunder, B.
    Mittapalli, R. K.
    Mohamed, M. -E. F.
    Friedel, A.
    Noertersheuser, P.
    Othman, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S63 - S63
  • [24] IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB: SUB-ANALYSIS OF ASIAN PATIENTS ENROLLED IN PHASE-3 CLINICAL TRIALS
    Tsai, W. C.
    Mu, R.
    Suh, C. H.
    Furtner, D.
    Lo, K. H.
    Zhou, Y.
    Hsia, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 447 - 448
  • [25] PATIENT REPORTED OUTCOMES AMONG PATIENTS RECEIVING TREATMENT FROM THE PEGLOTICASE PHASE 3 CLINICAL TRIALS FOR UNCONTROLLED GOUT
    Sparks, J.
    Obermeyer, K.
    Lamoreaux, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1643 - 1643
  • [26] Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database
    Sakai, Ryoko
    Tanaka, Eiichi
    Inoue, Eisuke
    Sato, Minako
    Tanaka, Masaru
    Ikari, Katsunori
    Yamanaka, Hisashi
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2023, 33 (05) : 899 - 905
  • [27] ANXIETY AND DEPRESSION AMONG RHEUMATOID ARTHRITIS PATIENTS, AND ASSOCIATION WITH CLINICAL MEASUREMENTS AND PATIENT REPORTED DISABILITY AND TREATMENT SATISFACTION
    Peterson, S.
    Li, N.
    Blackburn, S.
    Kielar, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 697 - 697
  • [28] USING PATIENT REPORTED OUTCOMES TO DESCRIBE THE PATIENT EXPERIENCE ON PHASE I CLINICAL TRIALS
    Ferrell, Betty
    Sedhom, Ramy
    Koczywas, Marianna
    Chung, Vincent
    Ruel, Nora
    Smith, Thomas
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 59 - 59
  • [29] The Interpretation of Patient-reported Outcomes in Rheumatoid Arthritis: Do Clinical Trials Adequately Evaluate Meaningful Improvements for Patients?
    Taylor, Peter
    Dore, Robin
    Williams, Kate
    Acaster, Sarah
    Antonova, Jenya
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] Efficacy and Safety of Upadacitinib in Patients Across Races with Rheumatoid Arthritis: A Post Hoc Analysis of Six Phase 3 Clinical Trials
    Wright, Grace
    Mysler, Eduardo
    Navarro-Millan, Iris
    Tanaka, Yoshiya
    Anyanwu, Samuel
    Liu, Jianzhong
    Tanjinatus, Oishi
    Garrison, Andrew
    Wells, Alvin
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 548 - 550
12345